Article

Curetoday.com's most-read articles and blogs of 2009

Author(s):

Melissa Weber

So, which stories caught your eye during the past year? Based on the top 10 most popular articles and blogs on curetoday.com, you sampled a little bit of everything--nutrition, treatment, finances, end of life, and late effects. We followed your clicks, and below are your faves in order of most viewed.

Top 10 Articles

1. The Vitamin D Difference

2. The Good Cancer?

3. The Internal Flame

4. Trying Something New

5. Targeting the Triple Threat

6. Battling Cancer Again

7. The Final Journey

8. Reining in Renal Cancer

9. Under the Sheets

10. Fatigue-Fighting Foods

Top 10 Blogs

1. PARP inhibitors create buzz at ASCO (June 8)

2. Tips for managing the financial cost of caregiving (June 24)

3. Finally, good news for triple-negative breast cancer patients! (June 9)

4. "So You Think You Can Dance" shows breast cancer struggle through art (July 24)

5. Study shows how to prevent rash from EGFR inhibitors (June 1)

6. Should you be concerned about the H1N1 virus (October 9)

7. Would you date a cancer survivor? (July 20)

8. Cancer survivors sought for online study (September 10)

9. Jonathan White is a fraud -- and other strange things (July 22)

10. Ductal carcinoma in situ: Is it cancer (September 29)

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Image of woman with text.
Related Content
Image of man with text.
August 1st 2025

Understanding Epithelioid Hemangioendothelioma: A Rare Vascular Cancer

Gina Mauro
Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.
The Importance of Spotting Endometrial Cancer
August 1st 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
FDA sign.
August 1st 2025

Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma

Ryan Scott
The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
August 1st 2025

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
A resilience program for young people with advanced cancer helped patients cope and led to a better quality of life: © stock.adobe.com.
August 1st 2025

How Resilience Coaching May Help Young People With Advanced Cancer

Spencer Feldman
A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life after 6 to 12 months.
Image of kidneys.
August 1st 2025

July GU Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.